Navigation Links
MODULITH® SLK

ProductsMODULITH® SLK
Company KARL STORZ Endoscopy-America, Inc.
Item MODULITH® SLK
Features 
  • Transportable Lithotripter with ultimate flexibility for the entire range of applications in ESWL and ESWT
  • Flexible cylindrical electromagnetic shock wave source
  • Dual imaging (In-line ultrasound and computer guided Lithotrack X-ray imaging)
  • Patient table with floating table concept (endourology table as an option)
  • X-ray C-arms of external suppliers can be adapted to the MODULITH SLK
Description The MODULITH SLK follows a completely new and revolutionary design: A medium sized shock wave source offering a wide energy range for all indications of shock waves is mounted on a flexible, easy-to-move, articulated arm. Different components of the treatment set-up like uro table, X-ray C-arc, ultrasound device etc. can be chosen from a variety of brands and models according to the specific needs and requirements of the hospital.These components can not only be used for ESWL! Diagnostics and urological procedures can also be performed utilising parts of the ESWL set-up. An endoscopic tower completes the urological workstation. And a detached use of X-ray C-arc or ultrasound device for example is also easily possible.
Info KARL STORZ Endoscopy-America, Inc.
Customer Service: (800) 421-0837
Web site: http://www.karlstorz.com

Related medicine products :

1. Cook® Cystostomy Catheters
2. Pelvicol Acellular Collagen Matrix (Continence)
Breaking Medicine Technology:Roper Industries Completes the Acquisition of Verathon, Inc. 2Roper Industries Completes the Acquisition of Verathon, Inc. 3Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 2Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 3Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 4Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 5Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 2Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 3Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 4Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 5Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 6Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 7Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 14 2009 56735 1Tianyin Pharmaceutical Co Inc Has Four Products Included in Chinas Essential Drug List 56734 1Tianyin Pharmaceutical Co Inc Has Four Products Included in Chinas Essential Drug List 56734 2Tianyin Pharmaceutical Co Inc Has Four Products Included in Chinas Essential Drug List 56734 3MDS Reports Third Quarter 2009 Financial Results 56733 1MDS Reports Third Quarter 2009 Financial Results 56733 2MDS Reports Third Quarter 2009 Financial Results 56733 3MDS Reports Third Quarter 2009 Financial Results 56733 4MDS Reports Third Quarter 2009 Financial Results 56733 5MDS Reports Third Quarter 2009 Financial Results 56733 6MDS Reports Third Quarter 2009 Financial Results 56733 7MDS Reports Third Quarter 2009 Financial Results 56733 8MDS Reports Third Quarter 2009 Financial Results 56733 9MDS Reports Third Quarter 2009 Financial Results 56733 10MDS Reports Third Quarter 2009 Financial Results 56733 11MDS Reports Third Quarter 2009 Financial Results 56733 12MDS Reports Third Quarter 2009 Financial Results 56733 13MDS Reports Third Quarter 2009 Financial Results 56733 14MDS Reports Third Quarter 2009 Financial Results 56733 15MDS Reports Third Quarter 2009 Financial Results 56733 16MDS Reports Third Quarter 2009 Financial Results 56733 17MDS Reports Third Quarter 2009 Financial Results 56733 18MDS Reports Third Quarter 2009 Financial Results 56733 19MDS Reports Third Quarter 2009 Financial Results 56733 20MDS Reports Third Quarter 2009 Financial Results 56733 21MDS Reports Third Quarter 2009 Financial Results 56733 22MDS Reports Third Quarter 2009 Financial Results 56733 23